Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/26 17:05 | 2/13/26 | CCCC | Health | BioPrd | Biological Products, (No Diag | Boyle Scott N | MA | O | Chief Bu | 1 | M.m | 0 | 0.00 | 0 | 26 | 10 | 299 | D | ||||||||||||||
2/18/26 17:05 | 2/14/26 | CCCC | Health | BioPrd | Biological Products, (No Diag | Mahaney Paige | MA | O | Chief Sc | 1 | M | 0 | 0.00 | 0 | 7 | 2 | 337 | D | ||||||||||||||
2/18/26 17:05 | 2/13/26 | CCCC | Health | BioPrd | Biological Products, (No Diag | Schick Kelly | MA | O | Chief Pe | 1 | M.m | 0 | 0.00 | 0 | 26 | 9 | 300 | D | ||||||||||||||
2/18/26 17:04 | 2/14/26 | CCCC | Health | BioPrd | Biological Products, (No Diag | Hirsch Andrew | MA | DO | P,CEO | 1 | M.m | 0 | 0.00 | 0 | 102 | 10 | 1,075 | D | ||||||||||||||
2/18/26 17:04 | 2/14/26 | CCCC | Health | BioPrd | Biological Products, (No Diag | Reyno Leonard | MA | O | Chief Me | 2 | M | 22 | 0.5421 | 0 | 41 | 12 | 380 | D | ||||||||||||||
2/18/26 17:04 | 2/13/26 | CCCC | Health | BioPrd | Biological Products, (No Diag | Adams Kendra | MA | O | CFO | 1 | M.m | 0 | 0.00 | 0 | 35 | 10 | 385 | D | ||||||||||||||
2/18/26 17:04 | 2/14/26 | CCCC | Health | BioPrd | Biological Products, (No Diag | Mossler Mark | MA | O | Chief Ac | 1 | M | 0 | 0.00 | 0 | 9 | 15 | 72 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |